Recreational cannabis was approved in the state in June 2021, sales began at the beginning of 2023, and medical cannabis has been legal since 2012.
In a statement (1) dated July 10, the Connecticut Department of Consumer Protection released data concerning sales of cannabis for recreational and medical purposes as collected through its Seed-to-Sale Tracking System.
In the month of June, recreational cannabis sales totaled $12.5 million (1). When combined with the $11.3 million in sales for medical purposes, the total amount of cannabis sales last month in the state totaled close to $24 million (1). In comparison, recreational sales and medical sales for January 2023 totaled $5.1 million and $8 million respectively (1). The statement did note that medical cannabis patients do not pay taxes on their products (1).
Also included was data on the types of products purchased. “In the first six months of sales, 53 percent of sales were usable cannabis, or flower, while vapes made up 25 percent of sales,” the statement also explained (1) “Edible products represented 10 percent of sales.”
The statement also noted that medical cannabis sales in the state were not required to be tracked prior to January 10, 2023 (1).
References
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
A Call for More Representative Horticultural Lighting Metrics for Cannabis Cultivation
March 5th 2025This article explores fundamental principles of photobiology, including Photosynthetically Active Radiation, photoreceptor-mediated responses, and the spectral influences on plant morphology and development.